Jump to content

Sarafloxacin

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Sarafloxacin
Clinical data
AHFS/Drugs.comInternational Drug Names
ATCvet code
Identifiers
  • 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H17F2N3O3
Molar mass385.371 g·mol−1
3D model (JSmol)
  • Fc1ccc(cc1)N\3c2cc(c(F)cc2C(=O)C(/C(=O)O)=C/3)N4CCNCC4
  • InChI=1S/C20H17F2N3O3/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24/h1-4,9-11,23H,5-8H2,(H,27,28) checkY
  • Key:XBHBWNFJWIASRO-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Sarafloxacin (INN) is a quinolone antibiotic drug,[1][2] which was removed from clinical use by its manufacturer Abbott Laboratories from April 30, 2001.

See also

References

  1. ^ "Evaluation of certain veterinary drug residues in food. Fiftieth report of the joint FAO/WHO Expert Committee on Food Additives". World Health Organization Technical Report Series. 888: i–vii, 1–95. 1999. PMID 10416362.
  2. ^ Gingerich WH, Stehly GR, Clark KJ, Hayton WL (1998). "Crop grouping: a proposal for public aquaculture". Veterinary and Human Toxicology. 40 (Suppl 2): 24–31. PMID 9823579.